tiprankstipranks
Trending News
More News >
Advanced Medical Solutions (GB:AMS)
:AMS
UK Market
Advertisement

Advanced Medical Solutions (AMS) Share Forecast & Price Target

Compare
25 Followers
See the Price Targets and Ratings of:

AMS Analyst Ratings

Moderate Buy
3Ratings
Moderate Buy
2 Buy
1 Hold
0 Sell
Based on 3 analysts giving stock ratings to
Advanced
Medical Solutions
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

AMS Stock 12 Month Forecast

Average Price Target

264.33p
▲(28.94% Upside)
Based on 3 Wall Street analysts offering 12 month price targets for Advanced Medical Solutions in the last 3 months. The average price target is 264.33p with a high forecast of 300.00p and a low forecast of 218.00p. The average price target represents a 28.94% change from the last price of 205.00p.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"182":"182p","301":"301p","211.75":"211.8p","241.5":"241.5p","271.25":"271.3p"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":300,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">300.00p</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":264.33,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">264.33p</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":218,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">218.00p</span>\n  </div></div>","useHTML":true}}],"tickPositions":[182,211.75,241.5,271.25,301],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2024","6":"Jan<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,201,208.6153846153846,216.23076923076923,223.84615384615384,231.46153846153845,239.07692307692307,246.69230769230768,254.30769230769232,261.9230769230769,269.53846153846155,277.15384615384613,284.7692307692308,292.38461538461536,{"y":300,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,201,205.87153846153845,210.74307692307693,215.61461538461538,220.48615384615385,225.3576923076923,230.22923076923075,235.10076923076923,239.97230769230768,244.84384615384613,249.7153846153846,254.58692307692306,259.4584615384615,{"y":264.33,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,201,202.30769230769232,203.6153846153846,204.92307692307693,206.23076923076923,207.53846153846155,208.84615384615384,210.15384615384616,211.46153846153845,212.76923076923077,214.07692307692307,215.3846153846154,216.69230769230768,{"y":218,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":189.13,"date":1704067200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":189.13,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":183.64,"date":1711929600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":214.34,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":209.4,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":239.04,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":195.86,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":210.14,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":223.02,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":197.25,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":203.7,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":210,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":201,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target300.00pAverage Price Target264.33pLowest Price Target218.00p
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TR | OpenAI - 4o Analyst forecast on GB:AMS
TR | OpenAI - 4o
TR | OpenAI - 4o
216p218p
Hold
6.34%
Upside
Reiterated
08/28/25
AI Generated ArticleAI Generated Article
Deutsche Bank  Analyst forecast on GB:AMS
Deutsche Bank
Deutsche Bank
275p
Buy
34.15%
Upside
Reiterated
07/16/25
Deutsche Bank Keeps Their Buy Rating on Advanced Medical Solutions (AMS)
Berenberg Bank Analyst forecast on GB:AMS
Unknown Analyst
Berenberg Bank
Not Ranked
Berenberg Bank
300p
Buy
46.34%
Upside
Reiterated
07/15/25
Berenberg Bank Remains a Buy on Advanced Medical Solutions (AMS)
Stifel Nicolaus Analyst forecast on GB:AMS
Stifel Nicolaus
Stifel Nicolaus
245p
Buy
19.51%
Upside
Upgraded
04/28/25
Stifel Upgrades Advanced Medical Solutions (AMS:LN) to BuyStifel analyst Christian Glennie upgraded Advanced Medical Solutions (AMS:LN) from Hold to Buy with a price target of GBP2.45.
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TR | OpenAI - 4o Analyst forecast on GB:AMS
TR | OpenAI - 4o
TR | OpenAI - 4o
216p218p
Hold
6.34%
Upside
Reiterated
08/28/25
AI Generated ArticleAI Generated Article
Deutsche Bank  Analyst forecast on GB:AMS
Deutsche Bank
Deutsche Bank
275p
Buy
34.15%
Upside
Reiterated
07/16/25
Deutsche Bank Keeps Their Buy Rating on Advanced Medical Solutions (AMS)
Berenberg Bank Analyst forecast on GB:AMS
Unknown Analyst
Berenberg Bank
Not Ranked
Berenberg Bank
300p
Buy
46.34%
Upside
Reiterated
07/15/25
Berenberg Bank Remains a Buy on Advanced Medical Solutions (AMS)
Stifel Nicolaus Analyst forecast on GB:AMS
Stifel Nicolaus
Stifel Nicolaus
245p
Buy
19.51%
Upside
Upgraded
04/28/25
Stifel Upgrades Advanced Medical Solutions (AMS:LN) to BuyStifel analyst Christian Glennie upgraded Advanced Medical Solutions (AMS:LN) from Hold to Buy with a price target of GBP2.45.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Advanced Medical Solutions

1 Month
xxx
Success Rate
1/3 ratings generated profit
33%
Average Return
-8.27%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 33.33% of your transactions generating a profit, with an average return of -8.27% per trade.
3 Months
xxx
Success Rate
2/3 ratings generated profit
67%
Average Return
-3.10%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of -3.10% per trade.
1 Year
Kane SlutzkinDeutsche Bank
Success Rate
2/3 ratings generated profit
67%
Average Return
-1.90%
reiterated a buy rating last month
Copying Kane Slutzkin's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of -1.90% per trade.
2 Years
xxx
Success Rate
2/3 ratings generated profit
67%
Average Return
-1.90%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of -1.90% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

AMS Analyst Recommendation Trends

Rating
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Strong Buy
0
0
0
0
0
Buy
4
3
3
6
6
Hold
3
9
10
14
12
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
7
12
13
20
18
In the current month, AMS has received 6 Buy Ratings, 12 Hold Ratings, and 0 Sell Ratings. AMS average Analyst price target in the past 3 months is 264.33.
Each month's total comprises the sum of three months' worth of ratings.

AMS Financial Forecast

AMS Earnings Forecast

Next quarter’s earnings estimate for AMS is 0.06p with a range of 0.06p to 0.06p. The previous quarter’s EPS was 0.01p. AMS beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 50.00% of the time in the same period. In the last calendar year AMS has Preformed in-line its overall industry.
Next quarter’s earnings estimate for AMS is 0.06p with a range of 0.06p to 0.06p. The previous quarter’s EPS was 0.01p. AMS beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 50.00% of the time in the same period. In the last calendar year AMS has Preformed in-line its overall industry.

AMS Sales Forecast

Next quarter’s sales forecast for AMS is 110.40M with a range of 110.00M to 111.20M. The previous quarter’s sales results were 109.53M. AMS beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 55.07% of the time in the same period. In the last calendar year AMS has Outperformed its overall industry.
Next quarter’s sales forecast for AMS is 110.40M with a range of 110.00M to 111.20M. The previous quarter’s sales results were 109.53M. AMS beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 55.07% of the time in the same period. In the last calendar year AMS has Outperformed its overall industry.

AMS Stock Forecast FAQ

What is GB:AMS’s average 12-month price target, according to analysts?
Based on analyst ratings, Advanced Medical Solutions’s 12-month average price target is 264.33.
    What is GB:AMS’s upside potential, based on the analysts’ average price target?
    Advanced Medical Solutions has 28.94% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Advanced Medical Solutions a Buy, Sell or Hold?
          Advanced Medical Solutions has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Advanced Medical Solutions’s share price target?
            The average share price target for Advanced Medical Solutions is 264.33. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is 300.00p ,and the lowest forecast is 218.00p. The average share price target represents 28.94% Increase from the current price of 205p.
              What do analysts say about Advanced Medical Solutions?
              Advanced Medical Solutions’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 3 Wall Streets Analysts.
                How can I buy shares of Advanced Medical Solutions?
                To buy shares of GB:AMS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis